tirzepatide wegovy Zepbound versus Wegovy: Which one is better? EASO Recommends Semaglutide, Tirzepatide for

GLP-1RAs have been shown to significantly reduce postprandial levels of triglycerides, apolipoprotein (Apo) B48 and ApoC-III, independently of gastric emptying

Research also showed that those taking tirzepatide were more likely to achieve 5% or greater, 10% or greater, and 15% or greater weight loss, and lost more weight over 3, 6, and 12 months

The compound is one of the most-studied peptides in preclinical regenerative-research literature, with more than 100 published animal studies covering gastric and intestinal cytoprotection, tendon and ligament repair, angiogenic pathway activity, and central nervous system models

This guidance applies to compounded semaglutide and other prescribed GLP-1 medications